(Q45189219)

10 December 2017

title

A crucial role for forebrain adenosine A(2A) receptors in amphetamine sensitization (English)

1 reference

10 December 2017

author

Michael A Schwarzschild

7

object named as

Michael A Schwarzschild

1 reference

10 December 2017

Elena Bastia

1

1 reference

10 December 2017

Yue-Hang Xu

2

1 reference

10 December 2017

Angela C Scibelli

3

1 reference

10 December 2017

Yuan-Ji Day

4

1 reference

10 December 2017

Joel Linden

5

1 reference

10 December 2017

Jiang-Fan Chen

6

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

10 December 2017

published in

Neuropsychopharmacology

1 reference

10 December 2017

volume

30

1 reference

10 December 2017

issue

5

1 reference

10 December 2017

page(s)

891-900

1 reference

Adenosine A(2A) receptor antagonist treatment of Parkinson's disease

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

A2A antagonists as novel non-dopaminergic therapy for motor dysfunction in PD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Adenosine A2A antagonism reverses levodopa-induced motor alterations in hemiparkinsonian rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A(2A) adenosine receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Inactivation of adenosine A2A receptors selectively attenuates amphetamine-induced behavioral sensitization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Striatal A2A adenosine receptors differentially regulate spontaneous and K+-evoked glutamate release in vivo in young and aged rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Functional striatal hypodopaminergic activity in mice lacking adenosine A(2A) receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

CaMKIIalpha-Cre transgene expression and recombination patterns in the mouse brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Absence of the adenosine A(2A) receptor or its chronic blockade decrease ethanol withdrawal-induced seizures in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Opposing actions of an adenosine A2 receptor agonist and a GTP analogue on the regulation of dopamine D2 receptors in rat neostriatal membranes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

DARPP-32: regulator of the efficacy of dopaminergic neurotransmission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Persistent behavioral sensitization to chronic L-DOPA requires A2A adenosine receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

DARPP-32 and modulation of cAMP signaling: involvement in motor control and levodopa-induced dyskinesia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Lack of tolerance to motor stimulant effects of a selective adenosine A(2A) receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

A role for sensitization in craving and relapse in cocaine addiction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Using conditional mutagenesis to study the brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Adenosine A1 and A2A receptor antagonists stimulate motor activity: evidence for an increased effectiveness in aged rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

The neural basis of drug craving: an incentive-sensitization theory of addiction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Adenosine A2 receptor-mediated excitatory actions on the nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Roles of adenosine A(1) and A(2A) receptors in the expression and development of methamphetamine-induced sensitization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Upregulation of striatal adenosine A2A receptor mRNA in 6-hydroxydopamine-lesioned rats intermittently treated with L-DOPA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

A2a adenosine receptor gene expression in developing rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Presynaptic BDNF required for a presynaptic but not postsynaptic component of LTP at hippocampal CA1-CA3 synapses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with L-DOPA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300630

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300630

1 reference

Dimensions Publication ID

10 December 2017

1043680409

0 references

1 reference